Erin Michos to Anticholesteremic Agents
This is a "connection" page, showing publications Erin Michos has written about Anticholesteremic Agents.
Connection Strength
0.831
-
Lipid Management for the Prevention of Atherosclerotic Cardiovascular Disease. N Engl J Med. 2019 10 17; 381(16):1557-1567.
Score: 0.672
-
Applicability and Cost Implications for Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors Based on the ODYSSEY Outcomes Trial. Circulation. 2019 01 15; 139(3):410-412.
Score: 0.159